Farnesyl transferase inhibitors as anticancer agents-Reference-Cited by-同舟云学术

Farnesyl transferase inhibitors as anticancer agents

Published:2002-09 Issue:13 Volume:38 Page:1685-1700
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Haluska P,Dy G.K,Adjei A.A

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference129 articles.

1. Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity;Kato;Proc. Natl. Acad. Sci. USA,1992

2. A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and-independent growth of human tumor cell lines;Sepp-Lorenzino;Cancer Res.,1995

3. Inhibition of human tumor xenograft growth by treatment with the farnesyl transferase inhibitor B956;Nagasu;Cancer Res.,1995

4. Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts;Sun;Oncogene,1998

5. Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines;Lerner;Oncogene,1997

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of novel imidazole-based compounds via using sonication technique: Influence of chemical reaction manipulation, antiproliferative activity through apoptosis induction, cell migration inhibition, and antioxidant properties;Journal of Molecular Structure;2025-01

2. Targeting the RAS upstream and downstream signaling pathway for cancer treatment;European Journal of Pharmacology;2024-09

3. FTase inhibitors and cancer: prospects for use in targeted therapies;Medicinal Chemistry Research;2023-12-09

4. Phenothiazine- and Carbazole-Cyanochalcones as Dual Inhibitors of Tubulin Polymerization and Human Farnesyltransferase;Pharmaceuticals;2023-06-16

5. Moving Towards Dawn: KRas Signaling and Treatment in Pancreatic Ductal Adenocarcinoma;Current Molecular Pharmacology;2022-12